Trends in Survival After Surgery for Breast Cancer Metastatic to the Brain and Spinal Column in Medicare Patients: A Population-Based Analysis

被引:16
作者
Cahill, Kevin S. [1 ]
Chi, John H. [1 ]
Day, Art L. [1 ]
Claus, Elizabeth B. [1 ,2 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Dept Neurosurg, Sch Med, Boston, MA 02115 USA
[2] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
关键词
Breast cancer; Craniotomy; Laminectomy; Postoperative survival; Spinal fusion; NERVOUS-SYSTEM METASTASES; SURGICAL-TREATMENT; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; CNS METASTASES; CARCINOMA; TUMORS; TRASTUZUMAB; PREDICTION; RESECTION;
D O I
10.1227/NEU.0b013e31820773b2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Central nervous system (CNS) metastases are a common occurrence in patients with breast cancer and are identified in up to 30% of patients at autopsy. OBJECTIVE: To determine population-based estimates of survival times after surgical intervention for Medicare patients with metastatic breast cancer to the brain and spinal column. METHODS: Female breast cancer patients with metastases to the brain and spinal column and undergoing neurosurgical treatment were identified through the Surveillance, Epidemiology, and End Results-Medicare database. Estimates of survival were calculated with Kaplan-Meier estimation and a Cox proportional hazards model. RESULTS: There were 643 patients who underwent neurosurgical treatment of metastatic disease from 1986 to 2005. Of these patients, 264 underwent cranial surgery and 379 underwent spinal surgery. There were 40 deaths during the postoperative hospital admission for an inpatient postoperative death rate of 6.2%. Inpatient death has declined by approximately 50% for surgeries performed in the most recent decade; however, the 30-day mortality rate of 9.0% has remained constant. The median postoperative survival after cranial surgery was 7.8 months (95% confidence interval, 6.2-9.2), after laminectomy was 9.4 months (95% confidence interval, 6.3-15.7), and after spinal fusion was 15.7 months (95% confidence interval, 11.9-18.5). Survival after spinal fusion has increased by approximately 50% in the recent decade. Patients with increased survival after cranial surgery were younger, had fewer comorbidities, and had longer periods from breast cancer diagnosis to surgery. Patients with increased survival after spinal neurosurgery had lower-grade lesions and longer time periods from breast cancer diagnosis to surgical treatment. CONCLUSION: After surgically treated metastases, one-third of cranial patients and one-half of spinal patients are alive at 1 year. The overall postoperative survival has increased over time only for spinal fusion procedures.
引用
收藏
页码:705 / 713
页数:9
相关论文
共 50 条
  • [1] Population-based Analysis of Treatment and Survival in Women Presenting With Brain Metastasis at Initial Breast Cancer Diagnosis
    Wiksyk, Bradley
    Nguyen, David H.
    Alexander, Cheryl
    Truong, Pauline T.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (03): : 255 - 260
  • [2] Population-based outcomes after brain radiotherapy in patients with brain metastases from breast cancer in the Pre-Trastuzumab and Trastuzumab eras
    Karam, Irene
    Hamilton, Sarah
    Nichol, Alan
    Woods, Ryan
    Speers, Caroline
    Kennecke, Hagen
    Tyldesley, Scott
    RADIATION ONCOLOGY, 2013, 8
  • [3] Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database
    Shah, Chintan P.
    Mramba, Lazarus K.
    Bishnoi, Rohit
    Unnikrishnan, Athira
    Duff, Jennifer M.
    Chandana, Sreenivasa R.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (05) : 869 - 877
  • [4] Survival after surgery for spinal metastases: a population-based study
    Bhanot, Kunal
    Widdifield, Jessica
    Huang, Anjie
    Paterson, J. Michael
    Shultz, David B.
    Finkelstein, Joel
    CANADIAN JOURNAL OF SURGERY, 2022, 65 (04) : E512 - E518
  • [5] Trends in survival for patients with metastatic breast cancer: is survival improving?
    Giuliani, Jacopo
    Bonetti, Andrea
    TUMORI, 2015, 101 (04) : 347 - 352
  • [6] Improved Survival After Primary Tumor Surgery in Metastatic Breast Cancer A Propensity-adjusted, Population-based SEER Trend Analysis
    Warschkow, Rene
    Guller, Ulrich
    Tarantino, Ignazio
    Cerny, Thomas
    Schmied, Bruno M.
    Thuerlimann, Beat
    Joerger, Markus
    ANNALS OF SURGERY, 2016, 263 (06) : 1188 - 1198
  • [7] Improved survival in patients with isolated liver metastasis at initial diagnosis with surgery at primary and metastatic sites: A population-based study in patients with breast cancer
    Chai, Yue
    Chen, Yujie
    Liu, Jiaxuan
    He, Maiyue
    Jiang, Mingxia
    Xu, Binghe
    Li, Qiao
    THORACIC CANCER, 2023, 14 (27) : 2793 - 2803
  • [8] Predicting the Survival Benefit of Radiotherapy in Elderly Breast Cancer Patients: A Population-Based Analysis
    Li, Maoxian
    Tang, Jie
    Pan, Xiudan
    Zhang, Dianlong
    JOURNAL OF SURGICAL RESEARCH, 2024, 297 : 26 - 40
  • [9] Population-based outcomes after whole brain radiotherapy and re-irradiation in patients with metastatic breast cancer in the trastuzumab era
    Karam, Irene
    Nichol, Alan
    Woods, Ryan
    Tyldesley, Scott
    RADIATION ONCOLOGY, 2011, 6
  • [10] Survival trends and conditional survival in primary non-metastatic esophageal cancer: a SEER population-based study and external validation
    Sun, Wei
    Zhang, Xiaoyu
    Qiu, Zeting
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (10) : 2693 - +